Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-Center, Open-Label, Randomized, Controlled Trial of Phasix™ Mesh to Prevent Incisional Hernia Subsequent to Open Midline Laparotomy

NCT03911700 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT03911700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03911700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-Center, Open-Label, Randomized, Controlled Trial of Phasix™ Mesh to Prevent Incisional Hernia Subsequent to Open Midline Laparotomy
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 12, 2019
Completion date
August 31, 2031
Enrollment
477 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

open midline laparotomy